ArticleClinical drug investigation2023

Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence.

Inês Soares de Pinho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.